A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients.
Campione E, Lambiase S, Gaeta Shumak R, Galluzzo M, Lanna C, Costanza G, Borselli C, Artosi F, Cosio T, Tofani L, Dattola A, Di Daniele F, Bianchi L.
Campione E, et al. Among authors: galluzzo m.
Pharmaceuticals (Basel). 2023 Mar 31;16(4):526. doi: 10.3390/ph16040526.
Pharmaceuticals (Basel). 2023.
PMID: 37111283
Free PMC article.